Pathways to metabolic discoveries
Metabolic disorders occur when the body's usual metabolic processes are disrupted - numerous molecular pathways and thus, several organs, can be affected. These diseases can be congenital or acquired, each disease is often quite rare, however as a group the incidence is significant.
While some metabolic diseases have treatments, many others like obesity or non-alcoholic steatohepatitis (NASH), are in infancy when it comes to understanding the underlying processes and finding drug targets. Therefore, research for this class of diseases relies on discovering and quantifying biomarkers to elucidate underlying mechanisms and uncover novel drug targets.
At Revvity, for easy detection of a wide range of metabolic biomarkers, we offer fast and pre-validated metabolic assay reagents, kits, and imaging systems. To optimize your genomic research, we provide automated, yet flexible workflow solutions including nucleic acid isolation, PCR setup and NGS sample prep. From early detection to genomic analysis — we’re here to support you on the path to metabolic discoveries.
All information presented is for informational purposes only and is not intended for medical advice. For research use only. Not for use in diagnostic procedures.
